| J3380 | Injection, vedolizumab, intravenous, 1 mg | 20,700 | $20 | $351.9K |
| J1745 | Injection, infliximab, excludes biosimilar, 10 mg | 3,970 | $30 | $99.3K |
| J0897 | Injection, denosumab, 1 mg | 2,280 | $20 | $41K |
| 99214 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the… | 220 | $100 | $22.2K |
| 99213 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a low level of medical decision making, and/or the… | 310 | $70 | $20.4K |
| 96413 | Chemotherapy is a therapeutic procedure used for the treatment of cancer via the use of chemical agents. These chemical agents (drugs) work on the cancerous cells of the body to destroy them. These… | 190 | $110 | $19.8K |
| 99203 | The provider sees a new patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a low level of medical decision making, and/or the provider… | 130 | $70 | $9.8K |
| 99204 | The provider sees a new patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the provider… | 70 | $120 | $8.6K |
| 96365 | The provider administers the initial intravenous infusion of a medication or other substance for a period up to one hour to prevent, treat, or diagnose a condition or disease. | 110 | $50 | $5.8K |
| J3489 | Injection, zoledronic acid, 1 mg | 410 | $10 | $2.8K |